Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

Trial Locations (18)

10021

Eastside Comprehensive Medical Center, New York

20852

Capital Clinical Research Associates, Rockville

27103

Piedmont Medical Research Associates, Inc., Winston-Salem

32806

Clinical Neuroscience Solutions, Inc., Orlando

38119

Clinical Neuroscience Solutions, Inc., Memphis

48864

Summit Research Network (Michigan), Inc., Okemos

60181

Midwest Center for Neurobiological Medicine, Oakbrook Terrace

62025

Cunningham Clinical Research, LLC, Edwardsville

77401

Claghorn-Lesem Research Clinic, Bellaire

78229

Croft Group Research Center, San Antonio

80212

Radiant Research, Inc., Denver

80304

Alpine Clinical Research, Boulder

85016

Southwest Health, Ltd, Phoenix

98004

Northwest Clinical Research Center, Bellevue

98104

Summit Research Network (Seattle), LLC, Seattle

08021

CNS Research Institute, Clementon

08057

Center for Emotional Fitness, Moorestown

23112-3989

Dominion Clinical Research, Midlothian

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY